Importance: Public awareness of oral cancer is crucial for prevention, early detection, and improved survival rates. Knowledge gaps in Middle Eastern and North African countries and areas for public education need to be assessed.
Objective: To evaluate public knowledge and awareness of oral cancer, including risk factors, signs and symptoms, and protective measures, in Middle Eastern and North African countries.
Design, Setting, And Participants: This cross-sectional study was conducted using an open, web-based questionnaire from January to December 2022 across 13 Middle Eastern and North African countries (Saudi Arabia, Syria, Egypt, Jordan, Lebanon, Iraq, Sudan, Morocco, Algeria, Yemen, the United Arab Emirates, Qatar, and Oman). Participants were recruited from the general adult population via social media platforms.
Main Outcomes And Measures: Primary outcomes included knowledge of risk factors, signs and symptoms, and protective measures. Factors associated with good knowledge were evaluated based on age, sex, education level, country income level, smoking status, smokeless tobacco use, and exposure to dental education on oral cancer.
Results: Among 4197 participants (2243 aged 18-30 years [53.4%]; 2372 female [56.5%] and 1825 male [43.5%]), 1559 participants (37.2%) demonstrated good knowledge of oral cancer risk factors, 2028 participants (48.4%) were aware of its signs and symptoms, and 2478 participants (59.1%) recognized associated protective measures. Factors associated with good knowledge across all domains included university education (eg, risk factor knowledge: odds ratio [OR] vs ≤intermediate school, 1.52; 95% CI, 1.20-1.92), no tobacco use (eg, risk factor knowledge: OR for never smoking, 1.44; 95% CI, 1.20-1.74), and receiving education from a dentist (eg, risk factor knowledge: OR, 8.60; 95% CI, 7.33-10.08) at the P < .05 significance threshold. Being female (eg, 1491 females [62.9%] vs 987 males [54.1%] with good knowledge) and residing in upper-middle- or high- vs low- and lower-middle-income countries (eg, 1230 of 1891 participants [65.1%] vs 1248 of 2306 participants [54.2%] with good knowledge) were also associated with increased awareness of protective measures at the P < .00036 significance threshold with Bonferroni adjustment.
Conclusions And Relevance: This study found a significant lack of oral cancer awareness in Middle Eastern and North African populations, particularly among individuals with lower levels of education and those who used tobacco. Findings also underscore the critical role of dental professionals in improving public knowledge of oral cancer through targeted educational interventions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11886726 | PMC |
http://dx.doi.org/10.1001/jamanetworkopen.2025.0522 | DOI Listing |
Braz J Biol
March 2025
Centro Universitário CESMAC, Maceió, AL, Brasil.
Adenoid Cystic Carcinoma - ACC is a common neoplasm in major and minor salivary glands with a high risk of metastasis. Thus, the objective of the present study was to perform an analysis to better understand the histological grading systems of the ACC and its influence on tumor prognosis in terms of overall survival, disease-free and metastasis-free. This is a systematic review, with meta-analysis, based on the PRISMA parameters.
View Article and Find Full Text PDFJ Cancer Educ
March 2025
Département d´Odontologie, Faculté de Santé, Service d´Odontologie, Centre HospitalierUniversitaire, Université de Toulouse, 3 chemin des Maraîchers, Toulouse, 31400, France.
A patient who had undergone radiation therapy for cancer developed a white coating on their tongue. This was initially misdiagnosed as a fungal infection, leading to unnecessary treatment. The actual cause was dry mouth, a common side effect of radiation therapy.
View Article and Find Full Text PDFArch Dermatol Res
March 2025
Department of Dermatology, MD Anderson Cancer Center, Houston, TX, USA.
Aging Dis
February 2025
Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Nanozymes, which are nanomaterials that replicate the catalytic activities of natural enzymes in biological systems, have recently demonstrated considerable potential in improving cancer immunotherapy by altering the tumor microenvironment. Nanozyme-driven immune responses represent an innovative therapeutic modality with high effectiveness and minimal side effects. These nanozymes activate the immune system to specifically recognize and destroy cancer cells.
View Article and Find Full Text PDFInt J Cancer
March 2025
Center for Epigenetics & Disease Prevention, Texas A&M HEALTH, and Department of Translational Medical Sciences, Texas A&M University Naresh K. Vashisht College of Medicine, Houston, Texas, USA.
A previously reported clinical trial in familial adenomatous polyposis (FAP) patients treated with erlotinib plus sulindac (ERL + SUL) highlighted immune response/interferon-γ signaling as a key pathway. In this study, we combine intermittent low-dose ERL ± SUL treatment in the polyposis in rat colon (Pirc) model with mechanistic studies on tumor-associated immune modulation. At clinically relevant doses, short-term (16 weeks) and long-term (46 weeks) ERL ± SUL administration results in near-complete tumor suppression in Pirc colon and duodenum (p < 0.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!